SAFETY, PHARMACODYNAMICS, AND BLOOD PRESSURE EFFECTS OF ALN-AGT, AN RNA INTERFERENCE THERAPEUTIC TARGETING ANGIOTENSINOGEN, IN A RANDOMIZED SINGLE ASCENDING DOSE STUDY OF HYPERTENSIVE ADULTS

Authors :: Don Foster
Kenji Fujita
David J. Webb
George L. Bakris
Sagar Agarwal
Stephen Huang
Huy Van Nguyen
Akshay S. Desai
Giuseppe Fiore
Jamie Harrop
Jorg Taubel
Jiandong Lu
Peter Dewland
Yansong Cheng
Source :: Journal of Hypertension. 39:e8
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.

Subjects :: Blood pressure
Physiology
RNA interference
business.industry
Pharmacodynamics
Internal Medicine
Medicine
Pharmacology
Cardiology and Cardiovascular Medicine
Therapeutic targeting
business

Full Text Access

Tools